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strategy combining these systems may increase set up control 
and motion monitoring robustness. 
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Purpose or Objective: To study the impact of breathing 
motion on proton breast treatment plans using scanned 
proton beams. 
 
Material and Methods: The study cohort was composed of 
twelve thoracic patients who had CT-datasets acquired 
during breath-hold at inhalation phase, breath-hold at 
exhalation phase and in free breathing mode. Proton 
treatment plans were designed for the left breast for the 
breath-hold at inhalation phase and were subsequently 
recalculated for the breath-hold at exhalation phase. 
Similarly, plans devised for the CT acquired in free breathing 
mode were recalculated for the extreme breath-hold phases. 
Four different field arrangements were used for each 
patient: two plans with three fields and two with one field. 
The dosimetric features of the plans were compared from the 
point of view of their coverage of the target and the doses to 
the organs at risk. 
 
Results: Breathing motion led to a degradation of the dose 
coverage of the target (heterogeneity index increased from 
about 6% to 8-11%). Exhalation tended to decrease the lung 
burden (average dose 3.1-4.2 GyRBE), while inhalation 
increased it (average dose 4.7-5.8 GyRBE). The absolute 
values depended on the field arrangement, but the trend was 
similar across the plans considered. Smaller differences in 
dosimetric parameters were seen for the heart (average dose 
0.1-0.2 GyRBE) and the left anterior descending artery (2.0-
4.0 GyRBE). The absolute values of the dosimetric 
parameters corresponding to various breathing phases were 
rather small and their expected clinical impact is therefore 
quite small. Furthermore, the plans parameters in either 
breathing phase were generally superior to the corresponding 
ones that could be achieved with photon plans. 
 
Conclusion: The results of this study indicated that the 
differences between the mean dosimetric parameters of the 
plans corresponding to the two extreme breathing phases are 
not significantly different, thus suggesting that breathing 
might have little impact for the chosen beam arrangements 
in proton scanned beam planning for breast cancer. Further 
investigations are needed to investigate the impact of 
interplay effects and whether the conclusions might be 
extended beyond the population considered in this study. 
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Purpose or Objective: In SBRT of lung lesions, respiratory 
motion is commonly considered by 4DCT imaging to define 
the internal target volume (ITV). Dose optimization is often 
performed on average CT using VMAT-based treatment 
techniques. However, average CT data ignores individual 
respiratory motion patterns during dose delivery and thus 
fluctuations in density distribution in the ITV. Additionally, 
interaction of MLC dose modulation and variable target 
motion might result in under-dosage of the target volume 
(interplay effect). This study analyses the efficiency of 
flattening filter free dose delivery and its impact on interplay 
effects in lung SBRT. 
 
Material and Methods: SBRT treatment plans were created 
for a lung tumor phantom using VMAT techniques employing 
the flattening filter (FF) and flattening filter free (FFF) mode 
(600MU and 1400MU per min). The phantom consists of a high 
resolution 2D detector array plus solid-water, bone, lung and 
tumor inserts. It is mounted on a 4D motion platform to 
simulate regular and irregular tumor motion trajectories 
extracted from clinical 4DCT data with max peak-to-peak 
amplitudes of 1.6/2.3cm in SI and 1.2/2.4cm in AP. The ITV 
includes a 2cm x 2cm lung tumor (CTV) plus 1.8cm safety 
margin in SI. Changes in dose distributions through interplay 
effects were investigated by analyzing static reference and 
dynamic dose measurements in FF and FFF mode at regular 
and irregular tumor motion using a planning structure-based 
evaluation method. 
 
Results: VMAT techniques in FF and FFF mode achieved 
almost identical dose distributions at static measurements 
(plan comparison). FFF allowed for approximately 40% shorter 
treatment time. For regular tumor motion (TM), FFF resulted 
in greater under- and over dosages of approximately 5-10% 
compared to FF in the CTV (cf. figure 1 for dose differences 
of dynamic and static measurements). However, 
corresponding γ-passing maps illustrate the increased 
interplay effect. Furthermore, FFF generated considerable 
under-dosages in the CTV in case of irregular TM. γ-passing 
rates (local γ of 3% / 1mm) decreased from 68% to 62% for 
regular TM and 41% to 34% for irregular TM within the ITV (cf. 
figure 1). Dose area histograms for CTV and ITV 
complementarily confirm above changes in dose differences 
and γ-maps. 
 
 
 
Conclusion: FFF dose delivery in lung SBRT provides shorter 
treatment times. However, the risk of interplay effects is 
increased, in particular for irregular tumor motion. Further 
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analysis is required to evaluate the appropriateness of FFF in 
lung SBRT. 
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Purpose or Objective: An electromagnetic (ELM) system 
(Calypso, Varian Medical System, Palo Alto, CA, USA) based 
on sub-millimeter high frequency localization of three 
transponders permanently implanted in the prostate, was 
recently introduced for continuous real-time tracking of the 
tumor. Several studies of the tracks acquired over thousands 
of patients were reported in literature and allowed to give a 
detailed insight of intra-fraction prostate motion. Aim of this 
work was to develop and validate a tool to selectively filter 
the signal produced by the ELM transponders and to apply it 
for the evaluation of the amplitude of prostate motion only 
due to patient’s breathing. 
 
Material and Methods: To selectively filter the signal 
produced by ELM transponders a software was developed in 
the Matlab environment (version R2014b). Briefly, the 
developed software computes the power density spectrum 
(PDS) of the recorded tracks and isolates the ‘breathing 
peak’, i.e. the peak which is centered at the frequency 
corresponding to the breathing average frequency of each 
single analyzed session. A bandpass filter on the breathing 
peak is then applied to the original tracking data, in order to 
isolate the motion of the prostate due to the breathing of the 
patient. The software was validated with data recorded with 
QUASAR moving phantom, provided with an home-made 
insert of three transponders. Simulated breathing frequencies 
of 10, 12, 14, 16, 18, 20, 22 and 24 cycles per minute were 
recorded for at least one minute with the ELM system. After 
validation, tracks of 6 prostate patients who underwent EBRT 
were analyzed for a total of 180 treatments sessions. For 
each session, the corresponding maximum amplitude of 
prostate motion along the three main directions was 
obtained. Intra patients average data and standard deviations 
were reported along with the overall maximum amplitude. 
 
Results: For the in-phantom validation, the developed 
software automatically computed the correct cycles per 
minute within a 0.52% uncertainty. The average amplitudes 
of prostate motion due to patient’s breathing are listed in 
Table 1. As expected, the smallest motion resulted in left-
right direction. The limited standard deviations indicate a 
low intra-patient motion variability. For each patient, the 
overall maximum amplitude turned out to be not negligible, 
but at the same time less than 0.5 mm. 
 
Conclusion: A tool to quantify prostate motion due to 
patient’s breathing was successfully developed, validated and 
applied to a consistent number of treatments sessions. 
Although small compared to the motion caused by the 
modifications of near organs (i.e. bladder and rectum), the 
achieved results show that the motion associated to patient’s 
breathing should be carefully considered in the definition of 
an adequate Internal Target Volume. 
This work was partially funded by Associazione Italiana per la 
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Purpose or Objective: In proton therapy treatments of 
intraocular tumors, patients actively participate by fixating a 
red diode, prepositioned according to planning prescriptions, 
to stabilize gaze direction. This work aims to evaluate safety 
margins effectiveness against involuntary eye movement that 
may occur in the course of the treatment. 
 
Material and Methods: A custom eye tracking system (ETS), 
able to monitor eye position and orientation through 3D 
video-oculography techniques, was installed in a proton 
therapy (PT) treatment room (fig.1). All ocular PT centers 
are equipped with an in-room orthogonal X-ray imaging 
system used to verify treatment geometry. Tantalum radio-
opaque markers, sutured to the sclera of the diseased eye, 
aid to determine the gaze angle of the eye during simulation, 
and the correct eye position at treatment. During simulation, 
the ETS monitored the eye simultaneously with X-ray 
acquisition to assess the tantalum markers pose relative to 
eye position and orientation. As a result, the ETS was able to 
assess eye motion and markers position in physical 
coordinates during dose delivery. 
A first analysis was performed on two patients with three and 
two monitored treatment fraction respectively. Both patients 
had four implanted markers. To enable 3D localization of 
markers identified in X-ray images, the geometry of the 
imaging system was calibrated by means of the Direct Linear 
Transform (DLT) algorithm. We measured the distance 
between markers 3D position seen by the ETS during 
irradiation and identified on setup verification X-ray images 
acquired prior dose delivery to quantify intra-fraction eye 
motion. Margins expansions of 2.5 mm were applied laterally 
and distally. Median, interquartile range (IQR) and maximum 
values for the clip-to-clip distance are reported in table 1.  
 
